Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Lakatos, Peter Laszlo ^a   Hitre, Erika ^b   Szalay, Ferenc ^a   Zinober, Kerstin ^c   Fuszek, Peter ^a   Lakatos, Laszlo ^d   Fischer, Simon ^a   Osztovits, Janos ^a   Gemela, Orsolya ^a   Veres, Gabor ^a   Papp, Janos ^a   Ferenci, Peter ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^c UNIVERSITY OF VIENNA   (Austria)

^d Csolnoky Ferenc County Hospital   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CARD15 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA SCREENING; ETHNICITY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUNGARY; MALE; PROTEIN VARIANT; STATISTICAL SIGNIFICANCE; AGED; CANCER STAGING; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; IRRITABLE COLON; MIDDLE AGED; MUTATION; PATHOLOGY; REFERENCE VALUE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNGARY; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; MUTATION; NEOPLASM STAGING; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; VARIATION (GENETICS);

EID: 34147185351     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-54     Document Type: Article

References (29)

1. Parkin DM Global cancer statistics in the year 2000 Lancet Oncol 2001 2 533-543 10.1016/S1470-2045(01)00486-7 11905707
2. Fuszek P Horvath HC Speer G Papp J Haller P Fischer S Halasz J Jaray B Szekely E Schaff Z Papp A Bursics A Harsanyi L Lukovich P Kupcsulik P Hitre E Lakatos PL Location and Age at Onset of Colorectal Cancer in Hungarian Patients between 1993-2004. The High Number of Advanced Cases Supports the Need for a Colorectal Cancer Screening Program in Hungary Anticancer Res 2006 26 527-32 16739314
3. Lakatos PL Lakatos L Current concepts on the genetics of hereditary and sporadic colorectal cancer and the role of genetics in the patient management Orv Hetil 2006 147 449-56 16573174
4. Popat S Wort R Houlston RS Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: Implications for chemoresistance BMC Cancer 2006 6 150 1513242 16753067 10.1186/1471-2407-6-150
5. Fuszek P Lakatos P Tabak A Papp J Nagy Z Takacs I Horvath HC Lakatos PL Speer G Relationship between serum calcium and Ca19-9 levels in colorectal cancer World J Gastroenterol 2004 10 1850-52
6. Balkwill F Mantovani A Inflammation and cancer: Back to Virchow? Lancet 2001 357 539-45 10.1016/S0140-6736(00)04046-0 11229684
7. Rhodes JM Campbell BJ Inflammation and colorectal cancer: IBD associated and sporadic cancer compared Trends Mol Med 2002 8 10-6 10.1016/ S1471-4914(01)02194-3 11796261
8. Eaden JA Abrams KR Mayberry JF The risk of colorectal cancer in ulcerative colitis: A meta-analysis Gut 2001 48 526-35 10.1136/ gut.48.4.526 11247898
9. Lakatos L Mester G Erdelyi Z David G Pandur T Balogh M Fischer S Vargha P Lakatos PL Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of ulcerative colitis patients. Results of a population-based study Inflamm Bowel Dis 2006 12 205-11 10.1097/ 01.MIB.0000217770.21261.ce 16534422
10. Higaki S Akazawa A Nakamur H Yanai H Yoshida T Okita K Metaplastic polyp of the colon develops in response to inflammation J Gastroenterol Hepatol 1999 17 709-14 10.1046/j.1440-1746.1999.01938.x
11. Jaiswal M LaRusso NF Burgart LJ Gores GJ Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism Cancer Res 2000 60 184-90 10646872
12. Sipos F Molnar B Zagoni T Berczi L Tulassay T Growth in Epithelial Cell Proliferation and Apoptosis Correlates Specifically to the Inflammation Activity of Inflammatory Bowel Diseases: Ulcerative Colitis Shows Specific p53- and EGFR Expression Alterations Dis Colon Rectum 2005 48 775-86 10.1007/s10350-004-0831-5 15747078
13. Lakatos PL Fischer S Lakatos L Gal I Papp J Current concept on the pathogenesis of IBD: Crosstalk between genetic and microbial factors. Pathogenic bacteria, altered bacterial sensing or changes in mucosal integrity take "toll"? World J Gastroenterol 2006 12 1829 40 16609988
14. Berrebi D Maudinas R Hugot JP Chamaillard M Chareyre F De Lagausie P Yang C Desreumaux P Giovannini M Cezard JP Zouali H Emilie D Peuchmaur M CARD15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon Gut 2003 52 840-846 10.1136/gut.52.6.840 12740340
15. Bonen DK Ogura Y Nicolae DL Inohara N Saab L Tanabe T Chen FF Foster SJ Duerr RH Brant SR Cho JH Nunez G Crohn's disease-associated NOD2 variants share a signalling defect in response to lipopolysaccharide and peptidoglycan Gastroenterology 2003 124 140-146 10.1053/gast.2003.50019 12512038
16. Maeda S Hsu LC Liu H Bankston LA Iimura M Kagnoff MF Eckmann L Karin M NOD2 mutation in Crohn's disease potentiates NF-kB activity and IL-1b processing Science 2005 307 734-738 10.1126/science.1103685 15692052
17. Wehkamp J Harder J Weichenthal M Schwab M Schaffeler E Schlee M Herrlinger KR Stallmach A Noack F Fritz P Schroder JM Bevins CL Fellermann K Stange EF NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal a-defensin expression Gut 2004 53 1658-1664 10.1136/gut.2003.032805 15479689
18. Netea MG Kullberg BJ de Jong DJ Franke B Sprong T Naber TH Drenth JP Van der Meer JW NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: Implications for Crohn's disease Eur J Immunol 2004 34 2052-9 10.1002/eji.200425229 15214053
19. Buhner S Buning C Genschel J Kling K Herrmann D Dignass A Kuechler I Krueger S Schmidt HH Lochs H Genetic basis for increased intestinal permeability in families with Crohn's disease: Role of CARD15 3020insC mutation? Gut 2006 55 342-7 10.1136/gut.2005.065557 16000642
20. Hugot JP Chamaillard M Zouali H Lesage S Cezard JP Belaiche J Almer S Tysk C O'Morain CA Gassull M Binder V Finkel Y Cortot A Modigliani R Laurent-Puig P Gower-Rousseau C Macry J Colombel JF Sahbatou M Thomas G Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 2001 411 599-603 10.1038/35079107 11385576
21. Ogura Y Bonen DK Inohara N Nicolae DL Chen FF Ramos R Britton H Moran T Karaliuskas R Duerr RH Achkar JP Brant SR Bayless TM Kirschner BS Hanauer SB Nunez G Cho JH A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 2001 411 603-6 10.1038/35079114 11385577
22. Ahmad T Armuzzi A Bunce M Mulcahy-Hawes K Marshall SE Orchard TR Crawshaw J Large O de Silva A Cook JT Barnardo M Cullen S Welsh KI Jewell DP The molecular classification of the clinical manifestations of Crohn's disease Gastroenterology 2002 122 854-866 10.1053/ gast.2002.32413 11910336
23. Lakatos PL Lakatos L Szalay F Willheim-Polli C Osterreicher C Tulassay Z Molnar T Reinisch W Papp J Mozsik G Ferenci P Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn disease: phenotype-genotype correlations World J Gastroenterol 2005 11 1489-1495 15770725
24. Helio T Halme L Lappalainen M Fodstad H Paavola-Sakki P Turunen U Farkkila M Krusius T Kontula K CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease Gut 2003 52 558-562 10.1136/gut.52.4.558 12631669
25. Kurzawski G Suchy J Kladny J Grabowska E Mierzejewski M Jakubowska A Debniak T Cybulski C Kowalska E Szych Z Domagala W Scott RJ Lubinski J The NOD2 3020insC mutation and the risk of colorectal cancer Cancer Res 2004 64 1604-6 10.1158/0008-5472.CAN-03-3791 14996717
26. Alhopuro P Ahvenainen T Mecklin JP Juhola M Jarvinen HJ Karhu A Aaltonen LA NOD2 3020insC is not sufficient for colorectal cancer predisposition Cancer Res 2004 64 7245-7 10.1158/0008-5472.CAN-04-2364 15492242
27. Papaconstantinou I Theodoropoulos G Gazouli M Panoussopoulos D Mantzaris GJ Felekouras E Bramis J Association between mutations in the CARD15/ NOD2 gene and colorectal cancer in a Greek population Int J Cancer 2005 114 433-35 10.1002/ijc.20747 15578724
28. Gazouli M Mantzaris G Kotsinas A Zacharatos P Papalambros E Archimandritis A Ikonomopoulos J Gorgoulis VG Association between polymorphisms in the toll-like receptor4, CD14 and CARD15/NOD2 and inflammatory bowel disease in Greek population World J Gastroenterol 2005 11 681-685 15655821
29. Roberts RL Gearry RB Allington MDE Morrin HR Robinson BA Frizelle FA Caspase Recruitment Domain-Containing Protein 15 Mutations in Patients with Colorectal Cancer Cancer Res 2006 66 2532-2535 10.1158/ 0008-5472.CAN-05-4165 16510569